New York, NY – HighRes Biosolutions (‘HighRes’) of Beverly, MA, part of Axel Johnson Inc.’s family of businesses, has acquired Let’s Go Robotics (‘LGR’) of Carlsbad, CA, growing its product portfolio in the Life Sciences.

LGR’s specialized dispensing technology expands HighRes’ liquid handling capabilities and range of offerings. By combining LGR with HighRes’ existing product portfolio and CellarioOS, a web-based orchestration software, HighRes strengthens its ability to provide semi-automated and fully automated workflows for genomics and drug discovery labs. The acquisition bolsters HighRes’ impact by enhancing reproducibility and accelerating scientific outcomes for pharmaceutical and biotech companies.

“We are excited to welcome Let’s Go Robotics into the Axel Johnson family” said Sara Greenstein, President and CEO of Axel Johnson Inc. “By integrating LGR’s expertise with HighRes, we are advancing the tools and techniques that drive Life Sciences innovation and improve global health.”

A Strategic Investment in the Future of Life Sciences

This acquisition reinforces Axel Johnson Inc.’s long-term commitment to investing in foundational technologies that drive innovation in Life Sciences. Since acquiring HighRes in 2015, Axel Johnson Inc. has prioritized its growth, recognizing automation as a key enabler of progress in Life Sciences. Through focused investment, the company has fostered strong and sustainable expansion, continuously advancing next-generation products and software that enhance scientific discovery. With HighRes, Axel Johnson Inc. is building a leading platform that equips scientists with best-in-class automation tools.

Axel Johnson Inc. operates with a long-term investment philosophy, ensuring that its group companies have the resources, stability, and vision to grow beyond short-term market cycles. As a family-owned company, Axel Johnson Inc. is free from external liquidity pressures, allowing its businesses to focus on long-term success. Its commitment to sustainable growth is driven by the belief that premier companies shape the future of their industries. With a strong balance sheet and the financial strength to support innovation and expansion, Axel Johnson Inc. continues to build enduring businesses that drive progress in the Life Sciences and beyond.

About Axel Johnson Inc.

Axel Johnson Inc. is committed to using business as a force for positive change in the world. With a long-term investment horizon and a focus on innovation, sustainability, and industry leadership, Axel Johnson Inc. builds and grows businesses that make the world healthier, safer, and more sustainable.

Founded in 1920 and headquartered in New York City, the company is part of a five-generation family enterprise owned by the Johnson family of Stockholm, Sweden. Axel Johnson Inc. takes a hands-on, long-term approach to ownership, acquiring and operating industry-leading businesses to drive lasting enterprise value and meaningful societal impact. Learn more at www.axeljohnson.com.